Skip to main content
OpenTrials
Completed

NCT Number: NCT00268554

Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole

The purpose of this study is to determine whether dipyridamole enhances postocclusive reactive hyperaemia by increasing extracellular adenosine concentrations during ischemia and reperfusion. Furthermore we hypothesize that dipyridamole augments postocclusive reactive hyperaemia by increasing adenosine receptor stimulation.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–50 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Radboud university Nijmegen Medical Centre

Nijmegen, Gelderland, 6533 ZA, Netherlands

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • healthy volunteers between 18 and 50 years

Exclusion criteria

  • none specified

Treatment and study plan

dipyridamole

Drug

Caffeine

Drug

Primary outcomes

  1. forearm blood flow

Sponsors and collaborators

Lead sponsor

Radboud University Medical Center

Other

Registry information

Official study title

Enhancement of Postocclusive Reactive Hyperaemia

Important dates

Study start
2005
Study completion
2006
First posted
Dec 22, 2005
Registry last updated
Mar 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.